Technical Specifications
- Product: ACE-031
- Quantity: 1 mg
- Research Classification: ActRIIB-Fc fusion protein
- Target Pathway: Activin receptor type IIB (ActRIIB) ligand signaling
- Purity: 99.09% (HPLC-UV tested, current lot)
- Identity: Confirmed by LC-MS
- Form: White lyophilized powder
- Measured Net Content: 1.28 mg
- Lot: ACE1
Analytical & Testing
Each tested batch of ACE-031 undergoes analytical evaluation to verify identity, purity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for the tested lot.
For the current OPTMZ Peptides lot, independent testing reported:
- Identity (LC-MS): ACE-031 — Confirmed
- Purity (HPLC-UV): 99.09%
- Measured Net Content: 1.28 mg
- Appearance: White lyophilized powder
- Endotoxin Replicate 1: Pass
- Endotoxin Replicate 2: Pass
- Assay Sensitivity: ≤0.05 EU/mL
- Lot: ACE1
The laboratory reports HPLC with UV detection coupled with mass spectrometry (LC-MS), while endotoxin testing was performed using a Limulus Amebocyte Lysate assay in accordance with USP <85> under validated laboratory conditions.
Handling & Storage
ACE-031 should be handled by qualified professionals in controlled laboratory environments. Appropriate storage conditions should be maintained to preserve protein stability and structural integrity.
Avoid unnecessary exposure to heat, moisture, and repeated temperature fluctuations. Experimental preparation and handling procedures should follow validated laboratory protocols appropriate to the research application.
Research Context
ACE-031 has been investigated in controlled experimental systems involving TGF-β superfamily signaling and ActRIIB-associated pathways. Research areas include:
- Activin receptor type IIB pathway research
- Myostatin-associated signaling
- TGF-β superfamily ligand interactions
- Skeletal-muscle biology
- Cellular growth and differentiation pathways
- Ligand-receptor binding models
- Protein signaling mechanisms
- ActRIIB pathway modulation
These observations relate to experimental research and do not establish therapeutic efficacy or safety for human use.
Research Application Scope
ACE-031 continues to be relevant to experimental biology involving ActRIIB ligand interactions and TGF-β superfamily signaling.
Its engineered soluble receptor structure allows researchers to investigate ligand sequestration and downstream signaling associated with myostatin, activins, and related signaling proteins in controlled experimental models.
Use Statement
For laboratory research use only. Intended strictly for in vitro research applications.
Disclaimer
All products currently listed on this site are for research purposes ONLY.
Reviews
There are no reviews yet.